In 2017, the FDA issued a proposed rule that would set forth requirements and limits on the amount of N-nitrosonornicotine (NNN) in smokeless tobacco products. NNN is a known to have carcinogenic properties and is associated with elevated cancer risk for smokeless tobacco product use.